This article is more than 5 years old. Information may no longer be current.

ASH presents ‘bridge grants’ to 15 hematology researchers

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The American Society of Hematology recently announced the 15 investigators who will receive ASH Bridge Grants.

The 1-year, $100,000 grants will fund research proposals that, despite earning high scores, could not be funded by NIH due to significant reductions in funding.

The grant recipients are: Joel S. Bennett, MD, of the University of Pennsylvania; John G. Conboy, PhD, of the Lawrence Berkeley National Laboratory; John K. Cowell, PhD, of Georgia Regents University; Adam N. Goldfarb, MD, of the University of Virginia; Jordan Jacobelli, PhD, of National Jewish Health; Michael B. Jordan, MD, of Cincinnati Children’s Hospital; Neil E. Kay, MD, of Mayo Clinic; Jatinder K. Lamba, PhD, of the University of Minnesota; Keith McCrae, MD, of Cleveland Clinic; Joanne E. Murphy-Ullrich, PhD, of the University of Alabama at Birmingham; Elizabeta Nemeth, PhD, of the University of California, Los Angeles; Trista E. North, PhD, of Beth Israel Deaconess Medical Center; Alvin H. Schmaier, MD, of Case Western Reserve University; Demin Wang, PhD, of BloodCenter of Wisconsin; and Don M. Wojchowski, PhD, of Main Medical Center Research Institute and Tufts University School of Medicine.

The grants are intended to help ASH member investigators to their next NIH research grant by allowing them to gather additional data to strengthen the resubmission of their applications. To date, 44 hematologists have received grant funding since ASH committed $9 million in society funds to create the program in July 2012.

“Despite small signs of improvement, the current NIH funding climate is far from perfect and the impact on biomedical innovation has been devastating,” ASH President Linda J. Burns, MD, of the University of Minnesota said in a press release. “While our early success rates suggest that the ASH Bridge Grant program is making an impact, it is still a temporary fix for a larger problem. Lawmakers must understand the damaging effect that unpredictable funding will have on research and patients and invest in biomedical research.”